Search results

Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
Global Substrate Mapping and Targeted Ablation with Novel Gold-tip Catheter
Author(s): Michael Timothy Brian Pope , Timothy Rider Betts Added: 1 year ago

Electrophysiology & Arrhythmia
Author(s): Tina Baykaner , Junaid Zaman , Paul J Wang , et al Added: 3 years ago
Treatment of atrial fibrillation (AF) classically focuses on eliminating triggers near and from the pulmonary veins, which may initiate AF. However, the 1–2 year success rate of pulmonary vein isolation (PVI) remains 40–50% for persistent AF1,2 and 50–65% for paroxysmal AF,3–5 while supplementary linear lesions or extensive ablation at electrogram-targets have had disappointing results and may… View more

Electrophysiology & Arrhythmia
Ablation Lesion Assessment with MRI
Author(s): Lluis Mont , Ivo Roca-Luque , Till F Althoff Added: 2 years ago

Imaging & Diagnostics
Author(s): Seigo Yamashita , Ashok J Shah , Saagar Mahida , et al Added: 3 years ago
Catheter ablation therapy has been widely used for rhythm control in patients with atrial fibrillation(AF).1 Since the first report in 1994,2 several interventional techniques have been proposed for AF, including replication of the surgical Maze,2 targeting pulmonary vein (PV) foci,3 segmental ostial and circumferential PV isolation,4,5 ganglionated plexi ablation,6 linear lesions in the left… View more

Electrophysiology & Arrhythmia
Hybrid Ablation – AF and Beyond
Added: 12 months ago
Under the expert moderation of Prof Harry Crijns(Maastricht, NL), a leading international faculty comprising Prof Carlo de Asmundis(Brussels, BE), Prof Mark La Meir(Brussels, BE) and Dr Ashley Nisbet(Bristol, UK) examine which arrhythmias could benefit from a hybrid approach, review the practical implementation of hybrid ablation in IST, and consider learnings from persistent and long-standing AF… View more

Electrophysiology & Arrhythmia
Watch Now
Author(s): Stefan Spitzer Added: 2 years ago
Identify which patient groups are most likely to benefit from Atrial Fibrillation ablation and the optimal time for patient referral in this video with Professor Dr Stefan Spitzer. Key Learning Objectives: Which patients are likely to benefit most from ablation When to refer for ablation Practical guidance for improving access to ablation for relevant patients Additional Learning… View more

Electrophysiology & Arrhythmia
Atrial Tachycardias After Atrial Fibrillation Ablation: How to Manage?
Author(s): Yuan Hung , Shih-Lin Chang , Wei-Shiang Lin , et al Added: 3 years ago
AF is the most common clinical arrhythmia that causes severe adverse cardiovascular events, such as ischaemic stroke and acute heart failure.1 Triggers from the pulmonary vein (PV) have been identified as crucial ectopic sources that initiate AF and pulmonary vein isolation (PVI) is the cornerstone for catheter ablation of AF.2,3 Per the European and US AF guidelines, catheter ablation of AF is… View more

Electrophysiology & Arrhythmia
EHRA 2023 Symposium – Hybrid Ablation: AF and Beyond
Start date: Apr 16, 2023 End date: Apr 16, 2023
At 15:45 CET (9:45 ET) on 16 April at EHRA 2023 in Barcelona, ES, Radcliffe Education is hosting a CME-accredited symposium entitled 'Hybrid Ablation: AF and Beyond'. Under the expert moderation of Prof Harry Crijns (Maastricht, NL), a leading international faculty comprising Prof Carlo de Asmundis (Brussels, BE), Prof Mark La Meir (Brussels, BE) and Dr Ashley Nisbet (Bristol, UK) will examine… View more

Electrophysiology & Arrhythmia
Medtronic Completes Acquisition of Affera
Author(s): Rebecca Seidel Added: 1 year ago
Following the announcement of Medtronic's acquisition of Affera, hereRebecca Seidel, President, Cardiac Ablation Solutions, Medtronic discusses the burden presented by cardiac arrhythmias, the strategic appeal of Affera's portfolio, the perceived real-world benefits of the system, and the remaining challenges for better patient care. Discussion Points: 1. The prevalence of cardiac… View more

Electrophysiology & Arrhythmia
Author(s): Ramanan Kumareswaran , Francis E Marchlinski Added: 3 years ago
Ventricular tachycardia (VT) is one of the most challenging medical conditions faced by cardiac patients and physicians treating them. Antiarrhythmic medications have limited effectiveness and are frequently poorly tolerated.1–4 Catheter ablation is increasingly used to treat patients successfully.1,5–7 Most VTs can be ablated endocardially but some require epicardial mapping and ablation… View more

Electrophysiology & Arrhythmia